Modular Medical, Inc.: Solas Capital Management, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Solas Capital Management, LLC amended its Schedule 13G filing for Modular Medical, Inc., updating its beneficial ownership stake with the SEC under accession number 0001604867-26-000021. The amendment signals a change in the investment firm's position in the medical device maker, though the filing did not disclose the exact size of the stake or the direction of the change. Schedule 13G amendments are typically filed by passive investors when their ownership crosses or adjusts relative to the 5% threshold. Investors will watch for further disclosures to gauge whether Solas is accumulating or trimming its position in Modular Medical.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Solas Capital Management, LLC, Modular Medical, Inc.